Immix Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.32

+0.76 (+7.95%)

As of May 9, 1:52 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +16.1% upside

Low Target $7.05

Average Target $11.98

High Target $14.20

Current Price $10.32

Current
$10.32

Target
$11.98

$7.05 $11.98 avg $14.20

Scenario Analysis

Bear Case

$7.05

-31.7%

Low target

Base Case

$11.98

+16.1%

Avg target

Bull Case

$14.20

+37.6%

High target

Risk/Reward

1.2x

Balanced

Price in Context

52-Week High

$11.61

-11.1% from high

52-Week Low

$1.87

+451.9% from low

Target vs 52W High

$11.98

+3.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%